IP Library Granted Patent US 7,964,364
Granted Patent B2
US 7,964,364 · App. 10/169,898 · Granted Jun 21, 2011

Cell isolation method

Assignee: Nordiag ASA
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,964,364
App. No.
10/169,898
Granted
Jun 21, 2011
Kind
B2
Abstract

The present invention relates to a method of isolating cells from a sample which method comprises binding said cells to a solid support by means of a non-specific ligand immobilised on said solid support, particularly to a method of isolating microorganisms from a sample. Preferred ligands for use in such methods include carbohydrates and derivatives thereof. Also described is a kit for isolating microorganisms from a sample comprising: (a) a solid support having immobilised thereon a ligand which is capable of non-specific binding to microorganisms; (b) means for binding microorganisms to said solid support; optionally (c) means for lysing said cells; and optionally (d) means for binding nucleic acid released from said lysed cells to a solid support.

Claims (23)

1. A method of isolating cells from a sample which method comprises (a) binding said cells to a magnetic solid support by means of a non-specific ligand covalently attached to said solid support wherein said ligand is a polysaccharide comprising at least one of mannose, galactose and a derivative of mannose or galactose and wherein the cells bind to the saccharide moieties of said ligand; and (b) separating the solid support with the cells bound thereto from the remainder of the sample.

2. A method as claimed in claim 1 wherein the cells are microorganisms.

3. A method as claimed in claim 2 wherein the microorganisms are bacteria.

4. A method as claimed in claim 3 wherein representatives from at least 30% of the different bacterial species present in the sample are bound to said solid support.

5. A method as claimed in claim 3 wherein representatives from at least 60% of the different bacterial species present in the sample are bound to said solid support.

6. A method as claimed in claim 1 wherein the ligand is a nutrient.

7. A method as claimed in claim 1 wherein the ligand is selected from the group consisting of Gum, guar, carrageenan and mannan.

8. A method as claimed in claim 1 wherein the solid support is particulate.

9. A method as claimed in claim 1 which additionally comprises a step of identifying one or more of the cells bound to said solid support.

10. A method as claimed in claim 9 wherein the cells are identified using a cell type specific nucleic acid probe.

11. A method as claimed in claim 9 wherein the bound cells are lysed to release their nucleic acid.

12. A method as claimed in claim 11 wherein the released nucleic acid is bound to a solid support.

13. A method of detecting a microorganism in a sample, said method comprising:

(a) binding said microorganism to a magnetic solid support by means of a non-specific ligand covalently attached to said solid support wherein said ligand is a polysaccharide comprising at least one of mannose, galactose and a derivative of mannose or galactose and wherein the cells bind to the saccharide moieties of said ligand;

(b) separating the solid support with the cells bound thereto from the remainder of the sample; and

(c) identifying the microorganism bound to said solid support.

14. A method as claimed in claim 13 wherein step (c) comprises lysing the microorganisms.

15. A method as claimed in claim 14 wherein the nucleic acid released from said lysed microorganisms is bound to a solid support.

16. The method as claimed in claim 1 wherein the derivative is selected from the group consisting of aldonic acid, uronic acid, deoxy, amino, sulfated and alcohol derivatives of galactose and mannose.

17. The method as claimed in claim 13 wherein the derivative is selected from the group consisting of aldonic acid, uronic acid, deoxy, amino, sulfated and alcohol derivatives of galactose and mannose.

18. The method as claimed in claim 1 wherein said ligand comprises 13 or more covalently linked monosaccharide units.

19. The method as claimed in claim 13 wherein said ligand comprises 13 or more covalently linked monosaccharide units.

20. A method as claimed in claim 1 wherein the ligand comprises mannose.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF THE ASSIGNEE PREVIOUSLY RECORDED AT REEL: 047594 FRAME: 0890. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 22, 2019
From: DIASORIN IRELAND LIMITED
To: HAIN LIFESCIENCE GMBH
Reel/Frame 048413/0401 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2018
From: DIASORIN IRELAND LIMITED
To: HAIN LIFESCIENCE GMBH
Reel/Frame 047594/0890 →
CHANGE OF NAME Recorded Nov 27, 2018
From: BIOTRIN INTERNATIONAL LIMITED
To: DIASORIN IRELAND LIMITED
Reel/Frame 048175/0166 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2018
From: NORDIAG ASA
To: BIOTRIN INTERNATIONAL LIMITED
Reel/Frame 048175/0172 →
MERGER Recorded Jan 25, 2011
From: GENPOINT AS
To: NORDIAG ASA
Reel/Frame 025689/0107 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2002
From: REFSETH, UNN HILDE; KOLPUS, TONE
To: GENPOINT AS
Reel/Frame 013528/0695 →
Priority Claims (1)
GB 0001450.6 · Jan 21, 2000 · national
Continuity (1)
Related Publication 20030153028A1 · Aug 14, 2003